Cargando…

Integrated Genomic and Transcriptomic Analyses of Diffuse Large B-Cell Lymphoma With Multiple Abnormal Immunologic Markers

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is a highly aggressive subtype of lymphoma and related to autoimmune diseases (AIDs). Primary B-cell receptor-mediated AIDs are associated with poor clinical outcome of DLBCL. To further determine the role of immunological alterations on disease prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheng, Lingshuang, Fu, Di, Cao, Yiwen, Huo, Yujia, Wang, Shuo, Shen, Rong, Xu, Pengpeng, Cheng, Shu, Wang, Li, Zhao, Weili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882913/ https://www.ncbi.nlm.nih.gov/pubmed/35237512 http://dx.doi.org/10.3389/fonc.2022.790720

Ejemplares similares

Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma
por: Qin, Wei, et al.
Publicado: (2021)

Incidence, mortality, and survival analyses of patients with thymic lymphoma
por: Wang, Li, et al.
Publicado: (2022)

Comprehensive analyses unveil novel genomic and immunological characteristics of micropapillary pattern in lung adenocarcinoma
por: Huo, Yansong, et al.
Publicado: (2022)

Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era: A Real-World Study
por: Wu, Meng, et al.
Publicado: (2022)

New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma
por: Fujii, Kazuyasu
Publicado: (2018)

Transcriptomic Correlates of Immunologic Activation in Head and Neck and Cervical Cancer
por: Saiz-Ladera, Cristina, et al.
Publicado: (2021)

Genomic and transcriptomic characterization reveals B‐cell hyperactivation and immune evasion in hepatitis B virus‐associated diffuse large B‐cell lymphoma
por: Qin, Wei, et al.
Publicado: (2023)

The Addition of Ferritin Enhanced the Prognostic Value of International Prognostic Index in Diffuse Large B‐Cell Lymphoma
por: Shen, Ziyuan, et al.
Publicado: (2022)

Comparison of Nasopharyngeal MR, (18) F-FDG PET/CT, and (18) F-FDG PET/MR for Local Detection of Natural Killer/T-Cell Lymphoma, Nasal Type
por: Guo, Rui, et al.
Publicado: (2020)

Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies
por: Decruyenaere, Philippe, et al.
Publicado: (2023)

Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma
por: Zhang, Jun, et al.
Publicado: (2018)

Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma
por: Xu, Tianqi, et al.
Publicado: (2021)

Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Li, Peifeng, et al.
Publicado: (2021)

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma
por: Ji, Xiaoshuai, et al.
Publicado: (2020)

Secondary Diffuse Large B-cell Lymphoma Mimicking Meningioma
por: Garcia-Grimshaw, Miguel, et al.
Publicado: (2019)

Bilateral Primary testicular diffuse large B-CELL lymphoma
por: Trama, Francesco, et al.
Publicado: (2021)

High Dimensional Mass Cytometry Analysis Reveals Characteristics of the Immunosuppressive Microenvironment in Diffuse Astrocytomas
por: Fu, Weilun, et al.
Publicado: (2020)

Prognostic Significance of Systemic Immune-Inflammation Index in Patients With Diffuse Large B-Cell Lymphoma
por: Wang, Zanzan, et al.
Publicado: (2021)

Diffuse Large B-Cell Lymphoma: Clinical Presentation and Treatment Outcomes From the OncoCollect Lymphoma Registry
por: Nair, Reena, et al.
Publicado: (2022)

DNA Copy Number Changes in Diffuse Large B Cell Lymphomas
por: Cascione, Luciano, et al.
Publicado: (2020)

Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases
por: Sun, Dao-Ping, et al.
Publicado: (2021)

Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma
por: Zhang, Bingxin, et al.
Publicado: (2023)

The findings on the CEUS of diffuse large B cell lymphoma in abdomen: A case report and literature review
por: Zhang, Yu-Qing, et al.
Publicado: (2023)

Clinical Features and Prognostic Significance of NOTCH1 Mutations in Diffuse Large B-Cell Lymphoma
por: Li, Zhongqi, et al.
Publicado: (2021)

The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Post-chemotherapy pneumonia in Chinese patients with diffuse large B-cell lymphoma: Outcomes and predictive model
por: Zhao, Jinrong, et al.
Publicado: (2022)

Identification and validation of an immunological microenvironment signature and prediction model for epstein-barr virus positive lymphoma: Implications for immunotherapy
por: Yao, Chenjiao, et al.
Publicado: (2022)

Diffuse large B-cell lymphoma presenting as LUTS: Clinical practice points
por: Lokeshwar, Soum D., et al.
Publicado: (2021)

Chronic Heel Pain Found to Be Diffuse Large B-cell Lymphoma of the Calcaneus
por: Horner, Kevin J, et al.
Publicado: (2022)

Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era
por: Nair, Reena, et al.
Publicado: (2023)

miRNome expression analysis in canine diffuse large B-cell lymphoma
por: Elshafie, Nelly O., et al.
Publicado: (2023)

New treatment options in elderly patients with Diffuse Large B-cell Lymphoma
por: Arcari, Annalisa, et al.
Publicado: (2023)

Hematolymphoid tumor of prostate: Diffuse large B cell lymphoma case report
por: Ochirjav, Enkhee, et al.
Publicado: (2023)

The Prognostic Utility of (18)F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients
por: Li, Cong, et al.
Publicado: (2022)

A Patient With Focal Myositis and Primary Cutaneous Diffuse Large B-Cell Lymphoma: A Case Report
por: Wu, Quanxin, et al.
Publicado: (2021)

Circulating Tumor DNA Analyses as a Potential Marker of Recurrence and Effectiveness of Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer
por: Kuang, Peng-Peng, et al.
Publicado: (2021)

Identification of LINC00654-NINL Regulatory Axis in Diffuse Large B-Cell Lymphoma In Silico Analysis
por: Chen, Yinchu, et al.
Publicado: (2022)

Development and validation of platelet-to-albumin ratio as a clinical predictor for diffuse large B-cell lymphoma
por: Wang, Jinghan, et al.
Publicado: (2023)

Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma
por: Zhu, Yue, et al.
Publicado: (2022)

Transcriptomic Analyses and Potential Therapeutic Targets of Pancreatic Cancer With Concomitant Diabetes
por: Xu, Tingting, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_45j1dnivhfdenavu2f1tedgpvc